Notizie dei mercati

PLx Pharma Inc.: Oppenheimer passa a un giudizio Neutral

This content has been archived. It may no longer be relevant

PLx Pharma Inc.: Oppenheimer passa a un giudizio Neutral

Pharma Oppenheimer passa


FIMA2681# 2022-08-15T16:01:03+02:00

Show More